These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 1656896

  • 1. High density of beta 2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT).
    Steinkraus V, Körner C, Steinfath M, Mensing H.
    Arch Dermatol Res; 1991; 283(5):328-32. PubMed ID: 1656896
    [Abstract] [Full Text] [Related]

  • 2. Radioligand binding characteristics of beta 2-adrenoceptors of cultured melanoma cells.
    Steinkraus V, Nose M, Mensing H, Körner C.
    Br J Dermatol; 1990 Aug; 123(2):163-70. PubMed ID: 1976019
    [Abstract] [Full Text] [Related]

  • 3. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
    D'Allaire F, Atgié C, Mauriège P, Simard PM, Bukowiecki LJ.
    Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
    [Abstract] [Full Text] [Related]

  • 4. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
    Sarsero D, Molenaar P, Kaumann AJ.
    Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
    [Abstract] [Full Text] [Related]

  • 5. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
    Germack R, Starzec AB, Vassy R, Perret GY.
    Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
    [Abstract] [Full Text] [Related]

  • 6. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.
    Nanoff C, Freissmuth M, Schütz W.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983
    [Abstract] [Full Text] [Related]

  • 7. A reliable assay for beta-adrenoceptors in intact isolated human fat cells with a hydrophilic radioligand, [3H]CGP-12177.
    Lacasa D, Mauriège P, Lafontan M, Berlan M, Giudicelli Y.
    J Lipid Res; 1986 Apr; 27(4):368-76. PubMed ID: 2873196
    [Abstract] [Full Text] [Related]

  • 8. Binding of beta-adrenergic receptors in human skin.
    Steinkraus V, Steinfath M, Körner C, Mensing H.
    J Invest Dermatol; 1992 Apr; 98(4):475-80. PubMed ID: 1312566
    [Abstract] [Full Text] [Related]

  • 9. Selective labelling of beta 1-adrenoceptors in rabbit lung membranes by (-)[3H]bisoprolol.
    Wang XL, Brinkmann M, Brodde OE.
    Eur J Pharmacol; 1985 Aug 15; 114(2):157-65. PubMed ID: 2864272
    [Abstract] [Full Text] [Related]

  • 10. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
    Kitagawa Y, Adachi-Akahane S, Nagao T.
    Br J Pharmacol; 1995 Sep 15; 116(1):1635-43. PubMed ID: 8564230
    [Abstract] [Full Text] [Related]

  • 11. Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells.
    Porzig H, Becker C, Reuter H.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov 15; 321(2):89-99. PubMed ID: 6296703
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA, Creese I.
    Mol Pharmacol; 1989 Jul 15; 36(1):201-10. PubMed ID: 2546050
    [Abstract] [Full Text] [Related]

  • 13. Density and binding characteristics of beta-adrenoceptors in the normal and failing equine myocardium.
    Horn J, Bailey S, Berhane Y, Marr CM, Elliott J.
    Equine Vet J; 2002 Jul 15; 34(4):411-6. PubMed ID: 12117116
    [Abstract] [Full Text] [Related]

  • 14. Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro.
    Disatnik MH, Sampson SR, Shainberg A.
    Biochem Pharmacol; 1990 Sep 01; 40(5):1043-8. PubMed ID: 1975171
    [Abstract] [Full Text] [Related]

  • 15. Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.
    Sarsero D, Molenaar P, Kaumann AJ, Freestone NS.
    Br J Pharmacol; 1999 Dec 01; 128(7):1445-60. PubMed ID: 10602323
    [Abstract] [Full Text] [Related]

  • 16. Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177.
    De Paermentier F, Cheetham SC, Crompton MR, Horton RW.
    Eur J Pharmacol; 1989 Aug 29; 167(3):397-405. PubMed ID: 2572436
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C, Galitzky J, Fontana E, Atgié C, Lafontan M, Berlan M.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr 29; 359(4):310-21. PubMed ID: 10344530
    [Abstract] [Full Text] [Related]

  • 19. Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.
    Law MP.
    Br J Pharmacol; 1993 Aug 29; 109(4):1101-9. PubMed ID: 8104642
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.